Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Global is a single-step embryo culture medium used in assisted reproductive technology (ART) for the continuous, uninterrupted culture of human embryos from the zygote stage through to the blastocyst stage (Day 5/6). Developed by LifeGlobal Group (now CooperSurgical), it is designed to provide a stable and optimized nutrient environment, containing essential salts, amino acids, and energy substrates like glucose and lactate. By eliminating the need for media changes required by sequential systems, Global aims to reduce embryo stress, maintain stable pH and osmotic levels, and improve blastulation rates and clinical pregnancy outcomes in patients undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Global.